Chengdu Easton Biopharmaceuticals Co., Ltd. Class ASSE: 688513

Announcement on Voluntary Disclosure of U.S. FDA Approval for Methylene Blue Injection

· Issued by Chengdu Easton Biopharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of U.S. FDA Approval for Methylene Blue Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment